Skip to content
Open access

A Cumulative Electrical Risk Score Is Associated with Appropriate ICD Therapy in Primary-Prevention Patients with Reduced Ejection Fraction: A Single-Center Retrospective Study

Sep 2026 · Journal of Clinical Medicine · Vol 15 · 0 citations · 38 references
Medicine

TL;DR

A cumulative electrical risk score from the standard electrocardiogram was independently associated with appropriate ICD therapy and may add risk information beyond LVEF and warrant prospective, multicenter validation.

Abstract

Background: In heart failure with reduced ejection fraction (HFrEF), implantable cardioverter-defibrillators (ICDs) are used for the primary prevention of sudden cardiac death, yet many patients never receive appropriate therapy, and left ventricular ejection fraction (LVEF) alone poorly discriminates who will. We investigated whether a cumulative electrical risk score (ERS) derived from the surface electrocardiogram is associated with appropriate ICD therapy. Methods: In this single-center, retrospective study, 205 patients with HFrEF who underwent ICD implantation for primary prevention were classified according to whether they had received appropriate ICD therapy. A modified eight-parameter ERS was calculated from the baseline electrocardiogram. Associations were assessed using receiver operating characteristic (ROC) analysis and logistic regression. Results: The ERS showed moderate-to-good discrimination (AUC 0.795; p < 0.001); a cut-off of 3.5 yielded 91% sensitivity and 71.4% specificity. After adjustment for age, sex, LVEF, cardiomyopathy etiology, BNP and device duration, the ERS remained independently associated with appropriate ICD therapy (adjusted OR 2.189; 95% CI 1.246–3.845; p = 0.006). Conclusions: A cumulative electrical risk score from the standard electrocardiogram was independently associated with appropriate ICD therapy and may add risk information beyond LVEF. These retrospective findings warrant prospective, multicenter validation.

Read PDF

Similar papers

Open access Sep 2026

Predictive Value of the Electrical Risk Score for Ventricular Arrhythmias in Heart Failure Patients with Primary Prevention Implantable Cardioverter Defibrillators

Background: Implantable cardioverter defibrillators (ICDs) are essential for the primary prevention of sudden cardiac death in heart failure (HF); however, appropriate shocks increase mortality and impair quality of life. The electrical risk score (ERS) is an electrocardiographic (ECG)-based composite index with proven...

P. Aladağ, Ilke Erbay, N. E. Güdül et al. · 0 citations
Open access Aug 2026

Mortality reduction with implanted defibrillator for primary prevention of sudden death after Myocardial Infarction: temporal trends in the PROFID study.

In this analysis including a large cohort of post-myocardial infarction patients with reduced LVEF, the estimated mortality reduction associated with primary prevention ICD implantation progressively decreased over time.

Alireza Sepehri Shamloo, T. Chiba, J. G. Tijssen et al. · 0 citations
Sep 2026

Incremental Predictive Value of ECG Burden Added to Clinical Risk for Appropriate ICD Therapy Selection: Model Development and Internal Validation

Adding the ECG burden score did not improve discrimination beyond minimal clinical predictors and provided only minimal incremental clinical utility in predicting appropriate ICD therapy selection.

M. AlTaweel, Maysan Almegbel, A. Almusaad · 0 citations
Open access Aug 2026

Monocyte-to-High-Density-Lipoprotein Ratio Is Associated with Ventricular Arrhythmia in Patients with Implantable Cardioverter-Defibrillators: A Cross-Sectional Study

Background: Residual arrhythmic risk persists in recipients of implantable cardioverter-defibrillators (ICDs) despite guideline-based selection, and inexpensive markers that refine this risk are needed. The monocyte-to-high-density-lipoprotein ratio (MHR) integrates a pro-inflammatory (monocyte) and an anti-inflammator...

Murat Küçükukur, C. Ekmekçi · 0 citations
Sep 2026

Risk-Score Guided Estimation of Absolute Benefit From Beta-blockers after Myocardial Infarction in Patients Without Heart Failure.

AIMS To assess whether a modified clinical risk-score can stratify baseline risk and estimate expected absolute benefit from beta-blocker therapy in post-MI (myocardial infarction) patients with LVEF (left ventricular ejection fraction) ≥40%. METHODS This substudy of the BETAMI-DANBLOCK trial included patients with a...

H. Caglar, T. Holmager, A. Kristensen et al. · 0 citations
Open access Sep 2026

Etiology-Related Differences in Left Ventricular Remodeling and Left Atrial Function in Patients with Heart Failure and Reduced Ejection Fraction Referred for ICD/CRT Implantation

Background: Heart failure with reduced ejection fraction (HFrEF) may be caused by various factors. The etiology of HFrEF may influence prognosis and further management. Objectives: In this study we aimed to assess differences between ischemic and non-ischemic etiology in the context of clinical features, hemodynamic ev...

M. Dąbrowska, M. Potapowicz-Krysztofiak, M. Kiliszek et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.